• Worst Pills, Best Pills



• Health Letter



• Health Links



• Activist Courses



• Take Action!



• Drug Safety



• Healthcare Delivery



• Medical Devices



• Food Safety



• Occupational Health

Publications:

» (4/28/05) Supplement to Petition to the FDA to Withdraw the Lung Cancer Drug gefitinib (Iressa) from the Market (HRG Publication #1739) » (3/3/05) Petition to the FDA to remove the cancer drug gefitinib (IRESSA) from the market (HRG Publication #1728) » (6/10/03) Testimony of Sidney Wolfe, M.D. before Endocrinologic and Metabolic Drugs Advisory Committee concerning the use of growth hormone for idiopathic short stature (HRG Publication 1667a) » (5/15/03) Petition to the FDA to add a black box warning to the label of the cancer drug IRESSA (HRG Publication #1667) » (4/30/03) Letter to FDA expressing concerns about the pending approval of the cancer drug gefitinib (IRESSA) (HRG Publication #1665) » (4/4/99) Citizen's petition with the National Women's Health Network to the Food and Drug Administration to change the labeling on tamoxifen (Nolvadex). (HRG Publication #1479) » (10/29/98) Press Release Concerning FDA'S Approval of Tamoxifen to Reduce Incidence of Breast Cancer in Healthy Women Puts Women at Risk (HRG Publication #1464)

more resources

Because Public Citizen does not accept funds from corporations, professional associations or government agencies, we can remain independent and follow the truth wherever it may lead. But that means we depend on the generosity of concerned citizens like you for the resources to fight on behalf of the public interest. If you would like to help us in our fight, click here.